Since the inception of laparoscopic surgery, there has been an ongoing effort to develop an even more 'minimally invasive' approach to surgery. A novel example of such advancement can be found in laparoendoscopic single-site (LESS) surgery. Performing surgery through a single site of access holds the promise of decreased morbidity, lower blood loss, shorter convalescence, and improved cosmesis. Given the nonextirpative nature of the pyeloplasty procedure, this patient cohort has proven to be the ideal candidates for LESS surgery. The driving force behind adaptation of this newer technique can be attributed to innovations in access sites and devices, instrumentation, optics, and robotic-based assistance. There are now several studies in the published literature demonstrating the feasibility and efficacy of LESS pyeloplasty in both children and adults. Although comparative studies have failed to demonstrate any objective advantage of the LESS pyeloplasty operation, it is important to realize that LESS surgery is still a fairly new technique. Further technological developments and additional studies will ultimately define its role in the field of urologic surgery, and subsequently, its application for the pyeloplasty procedure.
Introduction
Laparoscopic surgery has increasingly assumed a central role in the management of both benign and malignant urologic diseases. Numerous studies have implicated that minimally invasive procedures can provide equivalent surgical outcomes with reduced morbidity when compared with their open counterparts. As a consequence, laparoscopy has become more integrated into mainstream practice and in some cases has evolved into the standard of care for certain procedures [Gallo et al. 2009; Best et al. 2004] . A prime example of this latter point is the pyeloplasty procedure for the treatment of adult ureteropelvic junction obstruction (UPJO), which in present day is almost exclusively performed via a minimally invasive (laparoscopic or robotic) approach.
Laparoendoscopic single-site (LESS) surgery is a novel and innovative technical modification of conventional laparoscopy whereby entire surgical procedures are performed via a single abdominal wall incision (Figure 1) . The potential benefits of LESS (as compared with conventional laparoscopy) include decreased morbidity, lower blood loss, shorter convalescence, and improved cosmesis. Despite such theoretical advantages, LESS has not been broadly adopted into mainstream urologic practices, even in high-volume tertiary care centers ]. Nonetheless, a compelling argument can be made that the adult pyeloplasty patient cohort represent the ideal candidates for LESS given that most patients are young, the pathology is benign, and the procedure is nonextirpative (thereby allowing for smaller incisions). In this review, we discuss technical considerations, current status, and future developments for LESS pyeloplasty.
Overview of LESS

Background
In 2007, several different surgeon groups presented contemporary urologic-based applications of LESS. Rane and Rao reported the first urologic use of a single multifunctional port (R-Port TM , Advanced Surgical Concepts, Ireland) in an abstract and video presentation at the 25 th World Congress of Endourology (Cancun, Mexico, October 2007) [Rane and Rao, 2008] . Later that same year, Raman and colleagues published their initial experience with single-site umbilical 'keyhole' laparoscopic nephrectomy in both a porcine model and early human clinical case series using a single 3-cm incision to introduce three adjacent trocars (two 5 mm and one 10 mm) [Raman et al. 2007] . Shortly thereafter, both Desai and colleagues and Kaouk and coworkers shared early data from the Cleveland clinic regarding initial single-port cases to address a variety of urologic pathologies Kaouk et al. 2008] .
Interestingly, while contemporary literature has reflected a rapid growth in the volume of LESS cases, the actual concept of single-site surgery has actually permeated through the surgical literature for over 30 years. In particular, in the early 1970s, Clifford Wheeless described over 4000 cases of single-port laparoscopic tubal ligation using an operating laparoscope and offset eyepiece [Wheeless, 1972] . Subsequent work from the general surgery literature has further highlighted both the appendectomy and cholecystectomy procedures as amenable to a single-site transumbilical approach [Navarra et al. 1997; Inoue et al. 1994] . A recent review by Canes and colleagues underscores the chronological progression from single case reports described above to small cases series as observed today [Canes et al. 2008 ].
Finally, an important consideration prior to subsequent discussion involves delineating the origin and definition of the term LESS. In short, the growth of single-site surgery generated a plethora of acronyms and terms coined by individual groups and institutions. The inherent limitation of such a reporting strategy was lack of standardization regarding the actual approach, instrumentation, and outcomes. Therefore, peer comparison became a challenge with the ultimate dilemma being 'are apples being compared with apples?'. To better standardize this nomenclature, a consensus conference convened in Cleveland, OH, in July 2008 to coin the term laparoendoscopic single-site surgery or LESS ]. While the full details are beyond the scope of this manuscript, several key features defined LESS cases and included: (1) a single port of entry into the abdominal cavity; (2) applicability to multiple locations including umbilical or extra-umbilical sites (abdomen, pelvis, thorax); (3) laparoscopic, endoscopic, or robotic-based platforms; (4) intraluminal or transluminal approaches; and (5) ancillary use of 2-mm needle instruments to enhance surgeon confidence and enhance patient safety.
Technical considerations
As with many novel surgical approaches, a principal determinant in the general use and application of LESS has been innovations in access sites and devices, instrumentation, optics, and robotic-based assistance. These are briefly described below in greater detail with consideration of the LESS pyeloplasty operation.
Abdominal access. LESS access sites can originate from a host of different anterior abdominal wall incisions including periumbilical, supraumbilical, Pfannensteil, and Gibson locations. In general, the periumbilical location is ideally suited for LESS pyeloplasty given the anatomic location of the target location (ureteropelvic junction) and superior cosmetic benefit. For patients with a greater body mass index (BMI), consideration should be made to shift this location cephalad and lateral to limit small and large bowel obstruction of the horizon of the camera view.
Access devices themselves can be grouped into two basic categories: custom-made disposable access devices and reusable trocars inserted via a single abdominal wall incision. Custom-made disposable devices all rely on the same basic concept; namely, creating a multiport interface between the peritoneal cavity and the anterior abdominal wall [Kommu and Rane, 2009] . While basic differences exist between access devices, all have demonstrated to be clearly suitable for LESS pyeloplasty procedures. As an example, Figure 1 demonstrates the use of the GelPort Device (Applied Medical, Rancho Santa Margarita, CA) used during a LESS pyeloplasty procedure. Reusable trocars present the benefit of cost savings, although specialized lowprofile head trocars are necessary to minimize extracorporeal collision during LESS [Raman et al. 2007 ].
Instrumentation. A fundamental tenet of basic laparoscopy is triangulation around the target organ. However, the very nature of 'singleincision' access precludes the ability to orient trocars in such a configuration and thereby presents the primary challenge of LESS surgery. Newer technologies designed to avoid frequent 'sword fighting' have included prebent and articulating instruments [Tracy et al. 2008 ]. In addition, utilizing rigid instruments of varying lengths affords the surgeon the ability to stagger hand positions to decrease additional extracorporeal clashing. Although these novel instruments are able to overcome the challenges of limited triangulation, many surgeons report difficulty in maintaining tensile strength to adequately dissect the tissues [Dev et al. 2011 ].
An additional constraint unique to LESS pyeloplasty involves suturing necessary for intracorporeal reconstruction of the ureteropelvic junction. Indeed, 'in-line' suturing with rigid needle drivers presents a significant challenge for LESS reconstructive procedures. Therefore, several solutions have been proposed. Both Cambridge Endoscopic devices (Framingham, MA) and Novare Surgical Systems (Cupertino, CA) have developed articulating needle drivers which permit intracoporal triangulation to facilitate suturing [Kommu and Rane, 2009 ]. Limitations to date have included the inherent learning curve necessary to improve suturing accuracy with articulating needle drivers, as well as the relatively bulky hand piece which can contribute to extracorporeal clashing. Alternatively, several groups have proposed using an accessory 2-mm needlescopic trocar during LESS cases as a means to manipulate tissue and facilitate triangulation for suturing. Finally, the Endostitch device (Covidien, Norwalk, CT), while requiring a 10-mm trocar for insertion, permits suturing that can largely be performed via a single trocar.
Optics. Adequate optical visualization of the operative field is a constant challenge for LESS cases. The crux of the problem centers on the camera being parallel or 'in line' with working instruments. One of the simplest techniques to improve optics is withdrawing the camera further away from the target organ thereby providing more of a panorama view of the operative field. This maneuver also creates a greater amount of intra-abdominal working space thereby limiting collision.
Alternatively, different types of video laparoscopes may present superior solutions during LESS cases. Perhaps the most commonly used laparoscope for present-day LESS cases is the Olympus Deflectable-Tip EndoEYE (Olympus America, Center Valley, PA). A principal advantage of this endoscope is that the articulating tip permits staggering of the operating surgeons hands and the camera assistant without compromising the quality of the surgical perspective. Additional strategies include using rigid video laparoscopes with the light cord in line with the shaft of the lens thereby minimizing potential collision of working instruments and a right-angle light source.
Finally, a future direction may include deployable camera based devices. One example of this is a transabdominal magnetic anchoring and guidance system (MAGS) as described by Jeffrey Cadeddu at the University of Texas Southestern Medical Center. The initial pilot work described deployment of an intra-abdominal laparoscope and multiple working instruments introduced via a single 1.5-cm port [Park et al. 2007 ]. Once passed into the abdomen, instruments are affixed to the abdominal wall using external magnetic anchors. By fixing internal instruments to external magnetic anchors, this platform allowed for unrestricted intra-abdominal movement of surgical instruments, creating the potential to realize benefits of single-incision laparoscopy while maintaining an operative perspective similar to that of standard laparoscopy. Subsequent work in human patients has further underscored the reality of a deployable type optical interface ].
Robotics and future platforms. With the evolution of robotic surgery and the da Vinci surgical system (Intuitive Surgical, Sunnyvale, CA, USA), surgeons have sought to further overcome the obstacles presented by single-site surgery with the novel technique of R-LESS. Figure 2 demonstrates the trocar orientation as well as intraoperative still photos of an R-LESS pyeloplasty procedure. R-LESS combines the decreased morbidity of single-incision surgery with the enhanced features of robotic surgery including: three-dimensional optics, reduction in natural tremor, and precise instrument articulation. The first clinical application of R-LESS was performed by colleagues in 2009 [Kaouk et al. 2009 ]. Since then, there have been additional reports of R-LESS including: prostatectomy, radical nephrectomy, partial nephrectomy, ureteral reimplantation with psoas hitch, amongst various other urologic procedures [White et al. 2009 ]. Recently, platform-specific instruments (VeSPA, Intuitive Surgical, Sunnyvale, CA) have been developed for LESS surgery [Haber et al. 2011] . Although preliminary results are encouraging, further experience is needed to evaluate the general applicability, feasibility, and cost considerations of R-LESS new technology.
While robotics present one alternate platform for LESS surgery, it is essential to recognize that other novel systems exist and have been implemented. For example, the SPIDER surgical system (TransEnterix, Durham, NC) is a flexible laparoscopic platform which permits the introduction of multiple instruments through a single abdominal wall incision. The unique design of this platform permits a range of flexible instruments to be introduced through articulating delivery tubes. Collectively, this system provides the potential for triangulation while minimizing collision and other ergonomic challenges. To date, both Haber and colleagues [Haber et al. 2011] and Salas and colleagues [Salas et al. 2011] have described early experience in both a porcine model and initial clinical application. It is likely that similar future platforms may develop although the role of such tools remains to be defined.
Clinical experience with LESS pyeloplasty
As surgeon interest grows and single-site technology evolves, we have seen a steady increase in the number of LESS surgery cases in recent years. In reality, however, the published experience with LESS pyeloplasty cases is largely restricted to a handful of small case series originating from centers of excellence. These are highlighted below with a subsequent focus on two sentinel papers that specifically compare the LESS pyeloplasty procedure to a conventional approach.
Initial case series
The majority of data regarding LESS pyeloplasty can be gleaned from larger LESS series published on a variety of indications. Desai and colleagues published outcomes from their initial 100 patients undergoing LESS surgery between October 2007 and December 2008 ]. Amongst this cohort of patients, 17 LESS pyeloplasty procedures were performed using the r-Port (Advanced Surgical Concepts, Wicklow, Ireland) with a variety of specialized bent/articulating instrumentation. Furthermore, two of these cases incorporated robotic assistance. Within the pyeloplasty cohort, the mean patient age was 39 with a mean BMI of 22.
Operative data noted a mean estimated blood loss of 79 ml (range, 10150 ml) with a mean operative duration of 236 min (range, 120360 min). All cases required accessory placement of a 2-mm port to facilitate suturing, while two additional cases required insertion of an ancillary 5-mm trocar. Finally, a single case required conversion to standard laparoscopy due to difficult mobilization of the ureter. From a convalescence perspective, the mean hospital duration was 2 days, return to work was 22 days, and compete convalescence occurred in 31 days. Among the pyeloplasty cohort, there were no reported complications. The success rate for the 16 patients with follow-up imaging was 93.5%.
White and colleagues published a very similarly designed study highlighting a single surgeon experience with their first 100 cases of urologic LESS surgery [White et al. 2009 ]. Included among the 100 cases were eight pyeloplasty procedures, one of which performed used a robotic operating platform. Abdominal access and the surgical procedure were accomplished by a variety of devices and instrumentation. For the pyeloplasty cohort, the mean estimated blood loss was 62.5 ml, operating room (OR) duration was 233 minutes, length of stay was 2.5 days, and visual analog pain (VAP) score was 2.75/10. Postoperative MAG3 diuretic renograms were all within normal limits, and complications included an incisional hernia in one of the eight cases. Overall, the authors report technical feasibility and high patient satisfaction; however, the learning curve is not insignificant.
Choi and colleagues recently reported on 171 consecutive cases of LESS surgery (98 conventional and 73 robotic) of which four were pyeloplasty procedures [Choi et al. 2011] . Interestingly, this group has highlighted used of a homemade single-port system whereby a size 7 powder-free surgical glove is fixed to a wound retractor with the fingers of the glove serving as de facto access sites. These authors noted similar observations to those noted above with a mean OR duration in pyeloplasty cases of 196 minutes, estimated blood loss of 80 ml, hospital duration of 4.5 days, transfusion rate of 0%, and one complication attributable to stent migration. It is likely that the longer hospital duration was simply a function of the country of origin and associated health care system.
Beyond these larger LESS series, Tugcu and colleagues have published two well-described series specifically regarding LESS pyeloplasty in an adult and pediatric cohort [Tugcu et al. 2011 [Tugcu et al. , 2010 The description of their adult cohort included 14 consecutive LESS AndersonHynes dismembered pyeloplasty cases performed between May and October of 2009 who had a mean follow up of greater than 6 months [Tugcu et al. 2010] . Of the 14 patients, eight were female, nine had left-sided obstruction, and the mean age was 39 years (range, 1965) . At the time of surgery, anterior crossing vessels were noted in seven (50%), high insertion in five (36%), and severe adhesions in two (14%) patients. Their technique utilized the SILS port (Covidien, Norwalk, CT) in all cases with a combination of flexible and articulating instruments and a high-definition rigid 5-mm 30 laparoscope. The authors noted successful completion in all cases with operative metrics very similar to the experiences highlighted above. One patient had a wound complication, and all patients had radiographic evidence of success at a mean follow up of 6.2 months (range, 38) . In this study, radiographic success was defined as improvement of hydronephrosis on intravenous urography or improved drainage on a diuretic renal scan. This same group has further translated their LESS pyeloplasty experience to the pediatric population whereby they recently highlighted outcomes from 11 children treated between January and December of 2009 [Tugcu et al. 2011] . Surgical outcomes from this cohort were favorable with a mean OR duration of 182 minutes (range, 160300), estimated blood loss of 97 ml (range, 80160), and hospital stay of 2 days (range, 13). Success rate was 100% and the authors noted that 'all parents seemed extremely satisfied with postoperative cosmetic outcome'.
Comparison with conventional laparoscopic pyeloplasty
While early pilot series are essential to demonstrate and document feasibility of LESS pyeloplasty, the most important factor is an objective comparison with the conventional laparoscopic approach. In that regard, level I evidence in the form of a prospective, randomized study is lacking.
Nonetheless, two well-constructed casecontrol retrospective series provide some metrics of comparison. These are described in greater detail in the following.
In 2009, Tracy and colleagues compared the outcomes of 14 LESS pyeloplasty cases with 28 conventional laparoscopic pyeloplasty procedures ]. The specific design used a previous cohort of 28 patients who underwent conventional laparoscopic repair matched 2:1 to the LESS cohort with regards to age and side of surgery. With this matching process, the authors noted no differences between the cohorts with regards to preoperative characteristics. The operative technique for LESS cases utilized a single 2.5-cm periumbilical incision with three adjacent 5-mm trocars. An additional 3-mm subxyphoid liver retractor was used for almost all right-sided cases, and suturing was facilitated by an accessory 5-mm lateral trocar that served as a drain site at the conclusion of the case. When comparing the cohorts, no differences were appreciated with respect to length of stay, morphine requirement, and complications. Interestingly, the authors did report lower median operative times (207 vs. 238 minutes) and estimated blood loss (30 vs. 73 ml) in patients undergoing LESS pyeloplasty (Table 1) . Follow-up imaging revealed a success rate of 96% at a mean follow up of 14.6 months for the conventional cohort and 100% at a mean follow up of 6.8 months for LESS. The authors concluded that while LESS surgery is feasible and efficacious, there did not appear to be any discernable differences between conventional laparoscopy and LESS with regard to perioperative outcomes for pyeloplasty.
More recently, Stein and colleagues presented a similar comparison of LESS pyeloplasty with the standard laparoscopic technique [Stein et al. 2011] . In this study, sixteen patients who underwent LESS pyeloplasty were matched 1:1 with 16 patients who underwent a standard laparoscopic repair. All cases were performed using a custommade access port (Triport, Advanced Surgical Concepts, Wicklow, Ireland) with an additional 2-mm accessory grasper to facilitate suturing. With the exception of lower body mass index in the LESS cohort (23 vs. 30), no differences were appreciated in demographic or perioperative variables of interest which included: age, side of surgery, approach (transperitoneal for all), presence of crossing vessel, estimated blood loss, operative time, length of stay, and morphine requirements (Table 1 ). In addition, there were no complications in either cohort. A very nice addition from this study when compared with the Tracy study discussed above was the addition of convalescence data beyond morphine equivalent requirement. In particular, the authors noted no significant advantage with regard to convalescence and quality of life variables based on this six-item nonvalidated questionnaire which was distributed to all patients. Of note, there was one question which inquired how patients would rate the surgical scar from 1 (not delighted) to 10 (very delighted). The standard cohort had a mean response of 9.5 (range 910); however, all 16 of the LESS patients responded with 10. All patients in both groups experienced clinical resolution of their symptoms; however, follow-up radionuclide scans revealed a T 1/2 > 20 minutes in one patient who underwent standard repair (mean follow up of 17 months) and in two patients who underwent LESS (mean follow up of 13 months). The authors concluded that in the constraints of their retrospective case control study no benefit was noted for LESS pyeloplasty over the standard laparoscopic procedure.
Clearly, these two retrospective studies underscore the need of prospective evaluation to delineate benefit (or lack thererof) for LESS pyeloplasty. (3), urinary tract infection (2), urine leak (2), hematuria (1), and upper extremity neuropraxia (1). The conclusion from this study is that precise suturing and retraction necessary for LESS reconstructive cases (i.e. pyeloplasty) present challenges even from high volume surgeons with extensive laparoscopic background.
Complications of LESS pyeloplasty
Conclusion
As patients and surgeons continue to seek for 'scarless 0 surgery coupled with better functional outcomes and decreased morbidity, we will likely continue to see the application and evolution of LESS surgery. Although there still exist several obstacles preventing widespread adoption of the technique, there are many promising technological advancements in the development pipeline which will hopefully create a more userfriendly learning curve. In theory, LESS pyeloplasty continues to represent the ideal procedure for such a novel approach given that there is no specimen to extract. There are now several studies which show the feasibility and efficacy of LESS pyeloplasty. To date, however, comparative studies have failed to demonstrate any objective advantage of the LESS pyeloplasty operation. Nonetheless, it is imperative to realize that LESS techniques are still in the early stages of development and additional studies with larger cohorts are required to more accurately determine its role in the field of urologic surgery, particularly in the repair of UPJO.
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